People · Operator
Named in public records as an officer, director or promoter · active 2012–2022 · Biotechnology, Healthtech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Biodesix Inc | — | Biotechnology | Series B | $175.4M | $635.0M | 2012 |
| Monteris Medical US, Inc. | — | Healthtech | Series B | $82.5M | $168.2M | 2016 |
| Accelerate Diagnostics, Inc | — | Biotechnology | Series B | $74.5M | $75.7M | 2012 |
Matthew Strobeck at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Matthew Strobeck on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John Patience | 2 | 2 |
| Jack Schuler | 2 | 2 |
| Mark Miller | 1 | 18 |
| Kirk Nielsen | 1 | 13 |
| Patrick Morand | 1 | 5 |
| Gregory Barrett | 1 | 4 |
| John Schellhorn | 1 | 4 |
| James Richardson | 1 | 4 |
| Robin Cowie | 1 | 3 |
| Joseph Biller | 1 | 3 |
| Joe Biller | 1 | 3 |
| James Reinstein | 1 | 3 |
| Richard Emmitt | 1 | 3 |
| David Brunel | 1 | 2 |
| Robert K Davidson | 1 | 2 |
| Frank Ronchetti | 1 | 2 |
| Gary Bantle | 1 | 2 |
| Robert Cawthorn | 1 | 2 |
| Kevin McGarry | 1 | 2 |
| Daniel Cole | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.